The CDC and WHO teamed up to warn the world about a concerning explosion in measles cases, suggesting that drop off of ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...